Fiuzat, M., Alemayehu, W., Ezekowitz, J., Westerhout, C., Whellan, D., Mulder, H., … Januzzi, J. (2019). Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial. In Journal of Cardiac Failure (Vol. 25, pp. S78–S78). Elsevier BV. https://doi.org/10.1016/j.cardfail.2019.07.221

Fiuzat, Mona, Wendimagegn Alemayehu, Justin Ezekowitz, Cindy Westerhout, David Whellan, Hillary Mulder, Tariq Ahmad, et al. “Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial.” In Journal of Cardiac Failure, 25:S78–S78. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.07.221.

Fiuzat M, Alemayehu W, Ezekowitz J, Westerhout C, Whellan D, Mulder H, et al. Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial. In: Journal of Cardiac Failure. Elsevier BV; 2019. p. S78–S78.

Fiuzat, Mona, et al. “Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial.” Journal of Cardiac Failure, vol. 25, no. 8, Elsevier BV, 2019, pp. S78–S78. Crossref, doi:10.1016/j.cardfail.2019.07.221.

Fiuzat M, Alemayehu W, Ezekowitz J, Westerhout C, Whellan D, Mulder H, Ahmad T, Adams K, Pina I, Anstrom K, Cooper L, Alhanti B, Sbolli M, Mark D, Leifer E, Felker M, O’Connor C, Januzzi J. Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial. Journal of Cardiac Failure. Elsevier BV; 2019. p. S78–S78.